Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities.
作者信息
Li Runkai, Yuan Ping, Ma Jianyong, Zhu Wengen
机构信息
Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
出版信息
Front Cardiovasc Med. 2023 May 2;10:1205870. doi: 10.3389/fcvm.2023.1205870. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities.社论：口服抗凝治疗对合并症房颤患者的影响
Front Cardiovasc Med. 2023 May 2;10:1205870. doi: 10.3389/fcvm.2023.1205870. eCollection 2023.
2
Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.韩国非瓣膜性心房颤动患者中口服抗凝剂的应用。
Int J Clin Pharm. 2019 Dec;41(6):1434-1441. doi: 10.1007/s11096-019-00901-8. Epub 2019 Sep 14.
3
Emergency Medicine Physician Attitudes toward Anticoagulant Initiation for Patients with Atrial Fibrillation.急诊医师对房颤患者抗凝治疗启动的态度。
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105474. doi: 10.1016/j.jstrokecerebrovasdis.2020.105474. Epub 2020 Nov 23.
4
Underutilization of oral anticoagulant therapy for stroke prevention in elderly patients with heart failure.
Am Heart J. 2000 Aug;140(2):219-20. doi: 10.1067/mhj.2000.108002.
5
Association Between Oral Anticoagulants and Stroke Severity at Onset in Elderly Patients with Cardioembolic Stroke Due to Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动所致老年心源性脑栓塞患者口服抗凝剂与发病时卒中严重程度的相关性。
J Stroke Cerebrovasc Dis. 2022 Mar;31(3):106264. doi: 10.1016/j.jstrokecerebrovasdis.2021.106264. Epub 2021 Dec 25.
6
Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded.老年心房颤动患者抗凝相关出血：医生的担忧往往毫无根据。
Arch Intern Med. 2003 Jul 14;163(13):1580-6. doi: 10.1001/archinte.163.13.1580.
7
Geographic and temporal variation in the treatment and outcomes of atrial fibrillation: a population-based analysis of national quality indicators.基于人群的国家质量指标分析：房颤治疗和结局的地域和时间变化。
CMAJ Open. 2022 Aug 2;10(3):E702-E713. doi: 10.9778/cmajo.20210246. Print 2022 Jul-Sep.
8
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况：SAMURAI-非瓣膜性心房颤动（NVAF）研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
9
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation.伴有房颤的缺血性脑卒中患者接受紧急再灌注治疗时的抗凝安全性。
Stroke. 2020 Aug;51(8):2347-2354. doi: 10.1161/STROKEAHA.120.030143. Epub 2020 Jul 10.
10
The evolving role of stroke prediction schemes for patients with atrial fibrillation.房颤患者卒中预测方案的演变角色。
Can J Cardiol. 2013 Oct;29(10):1173-80. doi: 10.1016/j.cjca.2013.06.001. Epub 2013 Aug 7.
引用本文的文献
1
Antithrombic effects of in a rat model of acute thrombosis: modulation of endothelial adhesion molecules and inflammatory factors.[具体药物名称]在大鼠急性血栓形成模型中的抗血栓作用：对内皮黏附分子和炎症因子的调节
Food Sci Biotechnol. 2024 Jun 28;34(1):269-276. doi: 10.1007/s10068-024-01625-w. eCollection 2025 Jan.
2
Aspirin-free P2Y12 inhibitor monotherapy immediately after percutaneous coronary intervention: A systematic review.经皮冠状动脉介入治疗后立即使用无阿司匹林的P2Y12抑制剂单药治疗：一项系统评价。
Heliyon. 2024 Aug 3;10(15):e35741. doi: 10.1016/j.heliyon.2024.e35741. eCollection 2024 Aug 15.
本文引用的文献
1
Atrial fibrillation.心房颤动。
Nat Rev Dis Primers. 2022 Apr 7;8(1):21. doi: 10.1038/s41572-022-00347-9.
2
Atrial Fibrillation and Ischemic Stroke: A Clinical Review.心房颤动与缺血性脑卒中：临床综述。
Semin Neurol. 2021 Aug;41(4):348-364. doi: 10.1055/s-0041-1726332. Epub 2021 Apr 13.
3
Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge.心房颤动的全球流行病学：日益严重的流行趋势及公共卫生挑战。
Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19.
4
Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis.口服抗凝剂在老年心房颤动患者中的有效性和安全性：系统评价和荟萃回归分析。
Age Ageing. 2018 Jan 1;47(1):9-17. doi: 10.1093/ageing/afx103.
5
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.阿哌沙班与华法林在伴有心房颤动和心脏瓣膜病患者中的比较：来自心房颤动患者阿哌沙班减少卒中和其他血栓栓塞事件（ARISTOTLE）试验的结果。
Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.
Zotero 插件